Immunovant (IMVT) is now covered by Sanford C. Bernstein. They set a "market perform" rating and a $28.00 price target on the stock.
Assessing Immunovant (IMVT) Valuation After Recent Share Price Weakness [Yahoo! Finance]
Immunovant Stock Up 30% as Investor Trims Stake by $3 Million, But Here's Why It Still Seems Bullish [Yahoo! Finance]
Immunovant, Inc. (IMVT) Analysts Raise Price Targets Following Q3 Earnings Update [Yahoo! Finance]
Assessing Immunovant (IMVT) Valuation As Shares Deliver A 25% One Year Return [Yahoo! Finance]